The deal will strengthens and expand Aptar’s digital portfolio
AptarGroup has acquired all operating assets and the proprietary portfolio of Cohero Health, a digital therapeutics company transforming respiratory disease management for asthma and chronic obstructive pulmonary disorder (COPD). Aptar Pharma has acquired Cohero Health’s turnkey digital health platform and device assets including: BreatheSmart Connect digital health platform, BreatheSmart App, HeroTracker Sensors and mSpirometer and cSpirometer lung function diagnostic sensors.
“Cohero Health further strengthens and expands Aptar’s digital portfolio, in this case, with a focus in respiratory disease management,” commented Sai Shankar, Aptar Pharma’s Vice President, Global Digital Healthcare Systems. “With this strategic bolt on, Aptar now has global capabilities to deploy digital respiratory health, utilizing either the Cohero or Aptar device portfolio/platform. The investment will also facilitate Aptar’s ability to provide diagnostic solutions in respiratory and a significant number of other disease categories.”
“Cohero and Aptar are simply a great fit presenting a unique opportunity to leverage the complementary strengths of both companies. Building on our robust platform and rich innovations, we expect this combination to position us to lead the way in delivering on our joint vision, developing digital therapeutics that provide patients a better future and bring our customers stability and greater breadth of digital tools, actionable data, services and solutions,” said Joe Condurso, Chief Executive Officer, Cohero Health, who will join Aptar Pharma.
Gael Touya, President, Aptar Pharma, added, “We are pleased to welcome the Cohero Health team to the Aptar Pharma family. The combination of Aptar and Cohero Health will bring additional value to our pharmaceutical customers as they seek to put more lifechanging respiratory treatments and tools into the hands of empowered patients. Together, we will work toward the ultimate goal of improving patient experiences and health outcomes.”